Elevai Labs, Inc. (ELAB)
ELAB moved a median of -1.44% 30 minutes after news, and -1.51% by the close. How ELAB actually reacts to news — the realized, point-in-time move the market made, measured across 364 labeled events over the last three years with zero look-ahead.
ELAB’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.63% | 35% | 355 |
| 30-min | -1.44% | 36% | 363 |
| 60-min | -1.33% | 37% | 363 |
| to close | -1.51% | 36% | 363 |
| Middle 50% of ELAB reactions | -4.32% to +0.99% |
|---|---|
| Median reaction (30-min) | -1.44% |
| Measured reactions | 364 |
Half of all Elevai Labs, Inc. news events land between -4.32% and +0.99% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ELAB moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ELAB's baseline. Nothing else.
Recent ELAB events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update | Press release | GlobeNewswire | -0.65% | +0.81% | |
| PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy | Press release | GlobeNewswire | +0.85% | -8.12% | |
| NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs | Press release | GlobeNewswire | — | -23.70% | |
| Form 8-K PMGC Holdings Inc. For: Sep 18 | SEC filing · Form 8-K | SEC EDGAR | +0.95% | +4.83% | |
| PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings | Press release | GlobeNewswire | +0.95% | +4.83% | |
| Form 8-K PMGC Holdings Inc. For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.36% | |
| NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications | Press release | GlobeNewswire | -0.58% | -1.95% | |
| Form 8-K PMGC Holdings Inc. For: Aug 21 | SEC filing · Form 8-K | SEC EDGAR | -5.11% | -9.54% | |
| PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio | Press release | GlobeNewswire | +1.25% | +8.04% | |
| PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss | Press release | GlobeNewswire | -2.20% | -10.54% | |
| NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight | Press release | GlobeNewswire | -4.54% | +0.91% | |
| PMGC Holdings Inc. Announces Anticipated Reverse Stock Split | Press release | GlobeNewswire | -1.34% | -29.08% | |
| Form 10-Q PMGC Holdings Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.47% | -3.82% | |
| PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially | Press release | GlobeNewswire | +4.44% | +1.11% | |
| PMGC Holdings Confirms Compliance with Nasdaq’s New $5 Million Market Value of Listed Securities Requirement | Press release | GlobeNewswire | +0.46% | +1.02% | |
| PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc. | Press release | GlobeNewswire | -2.85% | -0.37% | |
| NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License | Press release | GlobeNewswire | -3.06% | +4.92% | |
| NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications | Press release | GlobeNewswire | -0.93% | +0.93% | |
| NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression | Press release | GlobeNewswire | +7.54% | -11.11% | |
| Form 8-K PMGC Holdings Inc. For: Jul 02 | SEC filing · Form 8-K | SEC EDGAR | +7.54% | -11.11% | |
| Form 8-K PMGC Holdings Inc. For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -7.83% | |
| PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace | Press release | GlobeNewswire | -0.39% | +4.69% | |
| Form 8-K PMGC Holdings Inc. For: Jul 01 | SEC filing · Form 8-K | SEC EDGAR | +0.23% | -0.78% | |
| NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences | Press release | GlobeNewswire | +0.23% | -0.78% | |
| NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets | Press release | GlobeNewswire | -0.71% | -1.42% | |
| PMGC Holdings Highlights Advanced Precision Manufacturing Capabilities Supporting Space Exploration Supply Chains | Press release | GlobeNewswire | +2.17% | +2.17% | |
| Form 8-K PMGC Holdings Inc. For: Jun 05 | SEC filing · Form 8-K | SEC EDGAR | +1.30% | -8.44% | |
| NorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime Applications | Press release | GlobeNewswire | -2.11% | -1.24% | |
| Form 8-K PMGC Holdings Inc. For: Jun 01 | SEC filing · Form 8-K | SEC EDGAR | -2.11% | -1.24% | |
| PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets | Press release | GlobeNewswire | +2.16% | -4.32% | |
| GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc. | Press release | GlobeNewswire | -0.51% | -5.05% | |
| Form 10-Q PMGC Holdings Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.00% | +4.00% | |
| Form DEF 14A PMGC Holdings Inc. For: Jun 05 | SEC filing · Form DEF | SEC EDGAR | -1.00% | +4.00% | |
| PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q1 2026 Results and Files Form 10-Q; Total Assets Reach Over $26.0 Million, Up 102% from Year-End 2025 and 193% Year-over-Year | Press release | GlobeNewswire | -1.00% | +4.00% | |
| Form 8-K PMGC Holdings Inc. For: May 11 | SEC filing · Form 8-K | SEC EDGAR | -5.31% | -4.35% | |
| PMGC Holdings (NASDAQ: ELAB) Acquires A&B Aerospace, Inc. | Press release | GlobeNewswire | -5.31% | -4.35% | |
| Form DEF 14C PMGC Holdings Inc. For: May 04 | SEC filing · Form DEF | SEC EDGAR | -1.10% | -3.51% | |
| Form PRE 14A PMGC Holdings Inc. For: Jun 05 | SEC filing · Form PRE | SEC EDGAR | -1.10% | -3.51% | |
| Form 8-K PMGC Holdings Inc. For: Apr 28 | SEC filing · Form 8-K | SEC EDGAR | +2.10% | +6.72% | |
| NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans | Press release | GlobeNewswire | +2.10% | +6.72% | |
| UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological Disorders | Press release | GlobeNewswire | -0.72% | -0.78% | |
| Form DEF 14C PMGC Holdings Inc. For: Apr 27 | SEC filing · Form DEF | SEC EDGAR | +2.10% | +6.72% | |
| Form PRE 14C PMGC Holdings Inc. For: Apr 23 | SEC filing · Form PRE | SEC EDGAR | -2.28% | -12.63% | |
| Form 8-K PMGC Holdings Inc. For: Apr 23 | SEC filing · Form 8-K | SEC EDGAR | -2.87% | -6.37% | |
| NorthStrive Defense Tech Acquires Patented GPS-Denied Autonomous Drone Navigation Technology Option, Built for Defense and Counter-Unmanned Aircraft Systems | Press release | GlobeNewswire | -2.87% | -6.37% | |
| Form 8-K PMGC Holdings Inc. For: Apr 21 | SEC filing · Form 8-K | SEC EDGAR | -2.42% | -0.30% | |
| SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc. | Press release | GlobeNewswire | -2.42% | -0.30% | |
| Univest Securities, LLC Announces a $40 Million Equity Line Facility for its Client PMGC Holdings, Inc. (NASDAQ: ELAB) | Press release | GlobeNewswire | -0.33% | +1.63% | |
| Form 8-K PMGC Holdings Inc. For: Apr 16 | SEC filing · Form 8-K | SEC EDGAR | -1.01% | -17.38% | |
| Form PRE 14C PMGC Holdings Inc. For: Apr 17 | SEC filing · Form PRE | SEC EDGAR | -1.01% | -17.38% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ELAB section they belong to.
Where else ELAB is measured.
ELAB earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Elevai Labs, Inc.'s median reaction calculated?
Every labeled ELAB news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 364 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 36% of ELAB's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ELAB's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.